Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 169Head and Neck Neoplasms 151Carcinoma, Squamous Cell 33Neoplasm Metastasis 18Laryngeal Neoplasms 17Colorectal Neoplasms 17Tongue Neoplasms 16Neoplasms 16Mouth Neoplasms 16Recurrence 14Oropharyngeal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Salivary Gland Neoplasms 12Hypopharyngeal Neoplasms 11Carcinoma 11Laryngeal Diseases 10Breast Neoplasms 10Nasopharyngeal Carcinoma 9Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Sarcoma 5Pharyngeal Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Stomach Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Melanoma 4Lymphoid Interstitial Pneumonia 4

Interventions

Radiotherapy 1Emulsions 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperphagia × Cetuximab × Head & Neck × Clear all
NCT02236936 2020-05-01

AGMT_HNO_PN

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 3 Terminated
8 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Hyperphagia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡